Medicare Enrolled
Dr. Behnaz Haghighi Motlagh, M.D.
Addiction Medicine (Family Medicine) Physician · Laguna Niguel, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haghighi Motlagh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haghighi Motlagh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haghighi Motlagh
Dr. Behnaz Haghighi Motlagh is an addiction medicine physician in Laguna Niguel, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Haghighi Motlagh performed 6,145 Medicare services across 2,128 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haghighi Motlagh received a total of $3,993 from 48 pharmaceutical and/or device companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (family medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haghighi Motlagh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 9% volume in CA
$3,993 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,145
Medicare services
Top 9% in CA for addiction medicine (family medicine) physician
2,128
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~410 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,887 | $107 | $299 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
902 | $12 | $35 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
854 | $1 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
597 | $8 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
478 | $76 | $200 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
188 | $43 | $70 |
| Annual alcohol misuse screening, 5 to 15 minutes | 181 | $21 | $50 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
165 | $140 | $152 |
| Annual depression screening | 163 | $21 | $31 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
162 | $34 | $50 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
118 | $46 | $100 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
83 | $46 | $80 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
61 | $32 | $43 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
57 | $22 | $39 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
34 | $3 | $30 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
32 | $13 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $142 | $300 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
29 | $57 | $300 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
29 | $174 | $1,000 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
27 | $1 | $24 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
23 | $6 | $300 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
18 | $0 | $10 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $176 | $238 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
12 | $150 | $154 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
29.5% medium
70.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,993
Total received (2018-2024)
Avg $570/year across 7 years
Top 5% in CA for addiction medicine (family medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,943 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$772
2023
$885
2022
$732
2021
$720
2020
$235
2019
$388
2018
$260
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$232
AstraZeneca Pharmaceuticals LP
$147
Lilly USA, LLC
$82
IRONWOOD PHARMACEUTICALS, INC
$78
Exact Sciences Corporation
$51
Amgen Inc.
$23
Sumitomo Pharma America, Inc.
$22
GlaxoSmithKline, LLC.
$22
PFIZER INC.
$22
Novo Nordisk Inc
$21
Kowa Pharmaceuticals America, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Currax Pharmaceuticals LLC
$16
Lundbeck LLC
$16
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$913
Lilly USA, LLC
$593
AbbVie Inc.
$240
AstraZeneca Pharmaceuticals LP
$194
PFIZER INC.
$193
Novo Nordisk Inc
$165
Amgen Inc.
$133
Eisai Inc.
$127
Allergan, Inc.
$125
Currax Pharmaceuticals LLC
$113
Exact Sciences Corporation
$91
IRONWOOD PHARMACEUTICALS, INC
$78
Allergan Inc.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$52
Ironwood Pharmaceuticals, Inc
$47
Indivior Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$41
Biohaven Pharmaceuticals, Inc.
$39
Amarin Pharma Inc.
$38
Biohaven Pharmaceutical Holding Company Ltd.
$37
Orexigen Therapeutics, Inc.
$35
Nalpropion Pharmaceuticals LLC
$35
Nalpropion Pharmaceuticals, Inc.
$34
AbbVie, Inc.
$33
Galderma Laboratories, L.P.
$32
Endo Pharmaceuticals Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$32
TherapeuticsMD, Inc.
$29
Novartis Pharmaceuticals Corporation
$25
Alnylam Pharmaceuticals Inc.
$23
IMPEL PHARMACEUTICALS INC.
$23
Sumitomo Pharma America, Inc.
$22
GlaxoSmithKline, LLC.
$22
RedHill Biopharma Inc.
$22
Antares Pharma, Inc.
$22
Venclose Inc.
$22
LINUS HEALTH, INC.
$21
VIVUS, Inc.
$21
Kowa Pharmaceuticals America, Inc.
$21
ITI, Inc.
$19
VIVUS LLC
$19
Janssen Pharmaceuticals, Inc
$18
Hologic Sales and Service, LLC
$17
IBSA Pharma Inc.
$16
Lundbeck LLC
$16
Horizon Therapeutics plc
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Genentech USA, Inc.
$13
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AIRSUPRA · APTIMA · AREXVY · BIJUVA · BOTOX · CAPLYTA · CHANTIX · COLOGUARD · COMIRNATY · CONTRAVE · CORE COGNITIVE EVALUATION · Cologuard Collection Kit · Dayvigo · EMGALITY · EVRSF · FARXIGA · GEMTESA · IMVEXXY · INVOKANA · JARDIANCE · Kerendia · LINZESS · LYRICA · Linzess · MOUNJARO · Movantik · NASCOBAL · NEXLETOL · NURTEC ODT · ONPATTRO · Otezla · Otrexup · Ozempic · PREMARIN · QSYMIA · QULIPTA · QUVIVIQ · RAYOS · REXULTI · Rybelsus · SUBLOCADE · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TRINTELLIX · TRULICITY · Tirosint · Trintellix · Trudhesa · UBRELVY · VRAYLAR · Vascepa · Wegovy · XIFAXAN · Xofluza · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for addiction medicine (family medicine) physician in CA.
Geographic Context
Addiction medicine physicians within 10 mi
13
Per 100K population
0.4
County median income
$113,702
Nearest hospital
ALISO RIDGE BEHAVIORAL HEALTH, LLC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haghighi Motlagh is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement in the top 5% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haghighi Motlagh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haghighi Motlagh performed 1,887 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haghighi Motlagh receive payments from pharmaceutical companies?
Yes. Dr. Haghighi Motlagh received a total of $3,993 from 48 companies across 208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haghighi Motlagh's costs compare to other addiction medicine physicians in Laguna Niguel?
Dr. Haghighi Motlagh's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haghighi Motlagh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Addiction Medicine Physicians in Laguna Niguel
Browse addiction medicine physicians in Laguna Niguel ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in CA
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in CA
Which CA addiction medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology